Airtel took a bold step of raising tariffs by 25% starting this Friday, notwithstanding the risk attached to it. Does this mean brighter days ahead for the telecom sector? Take a look at this report
Redmi Note 11T 5G will launch in India on November 30, 2021
Prospects of lower global economic growth amid fresh Covid wave and reduction in bond buying by US Fed weighing on sentiment
Aramco had signed a non-binding letter of intent in August 2019 for a potential 20% stake in Reliance's oil-to-chemicals unit valued at about $15 billion
Analysts said market was factoring in a full $75 bn valuation for O2C segment. Irrespective of the refining and petrochem cycle, the key catalyst for the market was Aramco deal closure
Analysts pointed out that further tariff hikes could come in the next 18-24 months as the aim is to hit an ARPU of Rs 300 per user per month
Vi is expected to raise prices, but Jio's reaction to the hike will be critical: Experts
The Confederation of All India Traders (CAIT) on Monday demanded strict action against e-commerce giant Amazon for the alleged sale of marijuana on its platform
The NCDs will be listed on the Wholesale Debt Market of BSE
Currently, there is no separate disclosure on free cash flow generation by the different businesses; after spinoff each entity will report separate financials
Cardiac medicines accounted for the highest volumes in 2020. Despite the burden of diabetes rising, its share in volumes was low; however, its share in total value was higher
A saturated tractor market and increasing mechanisation provide the momentum
This investment comes weeks after a $75 million funding led by Kedaara Capital, alongside Sequoia Capital India and Blume Ventures
The amount has to be deposited with the Registrar of the National Company Law Appellate Tribunal (NCLAT)
The promoter group companies have a purchase offer size of up to 4.57 percent of total shares outstanding as of Sep-30, 2021
Suchirayu owns a multi-speciality hospital in Hubli with an operational capacity of 110 beds
The subscriber base of Airtel stood at 35.44 crore in September as against 35.41 crore users in August
Earlier this month, the Bharat Biotech manufactured Covaxin had received its WHO EUL status
The spokesperson said its objections are based on breach of contract and specific performance of the contract
Existing investor Sequoia India also participated in the Series B round